Aspen Pharmacare (APN.JO) Financial Analysis & Valuation | Quarter Chart
Aspen Pharmacare (APN.JO)
APN.JOPrice: $8.88
Fair Value: 🔒
🔒score
Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anesthetics, muscle relaxants, and topical agents u... more
Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies special... more
Description
Shares
| Market Cap | $39.43M | Exchange | JNB |
| Sector | Healthcare | Industry | Drug Manufacturers - Specialty & Generic |
| Country | ZA | CEO | Stephen Bradley Saad |
| IPO Date | 2000-01-04 | CAGR | 0.15% |
| Employees | 8,867 | Website | www.aspenpharma.com |
| Div. Yield | 1.46% | Payout Ratio | -0.47% |
| Buy Back Yield | 0.11% | Total Yield | 1.57% |
APN.JO chart loading...
Fundamentals
Technicals
| Enterprise Value | $79.25B | P/E Ratio | — |
| Forward P/E | 1196.79 | PEG Ratio | — |
| P/S Ratio | 1.66 | P/B Ratio | 0.79 |
| P/CF Ratio | 9.25 | P/FCF Ratio | 14.47 |
| EPS | — | EPS Growth 1Y | -76.67% |
| EPS Growth 3Y | -57.18% | EPS Growth 5Y | -78.19% |
| Revenue Growth 1Y | 3.62% | Gross Margin | 0.42% |
| Operating Margin | 0.16% | Profit Margin | -0.05% |
| ROE | -0.02% | ROA | -0.02% |
| ROCE | 0.05% | Current Ratio | 3.64 |
| Quick Ratio | 2.66 | Cash Ratio | 0.36 |
| Debt/Equity | 0.41 | Interest Coverage | 3.54 |
| Altman Z Score | 2.05 | Piotroski Score | 5 |